PARTNERING

LICENSING

​

​Princeton Biotechnology

Strategic Alliances and

The New Future of Medicine​

 

New Breakthrough 6-in-1 Prescription Drug, AHEALON®​

quickly works against pain, inflammation and infection

without side effects - a revolution in medical treatment

​​

​

​​​​​​​​​​​​​​​​​​​​​​​​

Developed after years of intensive effort, AHEALON® can finally give doctors what they have wanted for a long time:

aaaa

​​​        a safe

        effective

        fast acting

        easy to administer

        generally topically applied

aaa​a

AHEALON®

​hhhh

​6-in-1

General Purpose

Prescription Medicine

for:

aaaaa

​​    1.  Pain   can work in seconds

    2.  Inflammation   stop/reduce​

    3.  Infection   stop/reduce

    4.  Stimulate Healing

    5.  Scar Tissue   stop/minimize

    6.  Wound Bed Moisturization

a

​        Without debilitating

        side effects.

 

AHEALON® is helping to open the door to a new and wonderful golden age of medicine, where effective, fast acting and safe medicine, without unwanted side effects, will soon become the new world standard.

 

​AHEALON® is a Registered Prescription Drug in the USA. 

US Patent Pending.

USA FDA NDC 52793-700-02

www.ahealon.com

​

There are a number of therapeutic communities that AHEALON® can immediately address, such as the topical treatment of burn wounds. Burn victims are medicinally under-served worldwide; over 75% of all USA burn victims are under-treated for their pain because of their doctors’ concern with the long

term effects of opiates.   The topical application of AHEALON® can be prescribed for pain, to be used as needed (PRN), and can often stop burn pain in seconds to within a few minutes.​​​  

​

Since AHEALON® has the remarkable ability to address the major integral components:

​mmmmmm            

          pain

          inflammation

and    infection

​

​of almost all malady and disease presentations,

​

AHEALON​®

is in the unique position

of being able to address a large number of therapeutic communities.  ​

​​

Please view our Pipeline Section for a list of some of our therapeutic interests.​

​

If your company has a particular therapeutic focus, you are encouraged to contact us at ​

Princeton Biotechnology

to discuss strategic alliance

or license possibilities. 

​